Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / BGNE - Week In Review: RemeGen A Yantai Biologics Company Completes $515 Million Hong Kong IPO

BGNE - Week In Review: RemeGen A Yantai Biologics Company Completes $515 Million Hong Kong IPO

BeiGene Ltd.
  • Innoforce, a Hangzhou company, formed a JV with Thermo Fisher Scientific to build a large biologics and steriles drug development and manufacturing facility in the Hangzhou Airport Economic Demonstration Area.
  • Decheng Capital had good reason to be pleased when Merck paid $2.75 billion to acquire VelosBio, a company formed in 2017 to develop ROR1 ADCs for cancer.
  • Genscript USA, a division of China-headquartered Genscript Biotech, reported its cPass SARS-CoV-2 Neutralization Antibody Detection Kit was approved in the US under Emergency Use rules.

For further details see:

Week In Review: RemeGen, A Yantai Biologics Company, Completes $515 Million Hong Kong IPO
Stock Information
Company Name: BeiGene Ltd.
Stock Symbol: BGNE
Market: NASDAQ
Website: beigene.com
Menu
BGNE BGNE Quote BGNE Short BGNE News BGNE Articles BGNE Message Board
Get BGNE Alerts

News, Short Squeeze, Breakout and More Instantly...